Do common FADS gene variants make arachidonic acid levels more sensitive to omega-6 intake?

Genetic variation significantly influences how the body processes dietary fats, particularly the conversion of omega-6 fatty acids found in vegetable oils into biologically active compounds. The FADS1 and FADS2 genes are the primary determinants of this metabolic pathway, and common variants in these genes create meaningful differences in how individuals respond to their diet.

Clinical and metabolic evidence

Research consistently shows that common variants in the FADS gene cluster dictate an individual's efficiency in synthesizing arachidonic acid (AA) from linoleic acid (LA).

• Genotype-driven conversion: Individuals carrying "high-efficiency" alleles (often the ancestral G alleles at SNPs like rs174537) exhibit significantly higher delta-5 desaturase (Δ5D) activity. This leads to more efficient conversion of dietary LA into AA, with some studies showing p-values as significant as 10⁻⁴⁶ for this association.
• Reduced efficiency variants: Conversely, carriers of minor alleles (such as the T allele at rs174537) have roughly 40-60% reduced conversion efficiency. In these individuals, high intake of LA leads to an accumulation of precursor fatty acids rather than a significant rise in AA levels.
• Dietary sensitivity: Because these variants control the rate-limiting enzymes of the pathway, they create differential sensitivity to omega-6 intake. In "fast converters," increasing dietary LA directly correlates with higher circulating AA levels, whereas "slow converters" remain relatively buffered against such dietary increases.

Mechanistic explanations

The FADS gene cluster (FADS1, FADS2, and FADS3) encodes the enzymes required for the desaturation of polyunsaturated fatty acids (PUFAs).

• Enzymatic control: FADS1 encodes Δ5D, which catalyzes the final, rate-limiting step from dihomo-gamma-linolenic acid (DGLA) to AA. FADS2 encodes Δ6D, which initiates the process.
• Molecular regulation: Genetic variants influence these enzymes by altering gene expression through modified enhancer activity, miRNA binding, or DNA methylation. This molecular "tuning" determines the total capacity of the enzymatic "engine" to process dietary omega-6 precursors.

Bottom line

Common FADS gene variants act as a metabolic switch that determines how efficiently linoleic acid is converted to arachidonic acid. This makes arachidonic acid levels highly sensitive to dietary omega-6 intake in individuals with high-efficiency genotypes, while those with low-efficiency variants maintain more stable AA levels regardless of intake.